Functional Integrity of Nuclear Factor κB, Phosphatidylinositol 3′-Kinase, and Mitogen-Activated Protein Kinase Signaling Allows Tumor Necrosis Factor α-Evoked Bcl-2 Expression to Provoke Internal Ribosome Entry Site-Dependent Translation of Hypoxia-Inducible Factor 1α

Hypoxia-inducible factor (HIF)-1, a heterodimeric transcription factor composed of HIF-1α and HIF-1β subunits coordinates pathophysiologic responses toward decreased oxygen availability. It is now appreciated that enhanced protein translation of HIF-1α under normoxia accounts for an alternative regulatory circuit to activate HIF-1 by hormones, growth factors, or cytokines such as tumor necrosis factor α (TNF-α). Here, we aimed at understanding molecular details of HIF-1α translation in response to TNF-α. In tubular LLC-PK1 cells, activation of nuclear factor κB (NFκB) by TNF-α resulted in HIF-1α protein synthesis as determined by [35S]methionine pulse experiments. Protein synthesis was attenuated by blocking NFκB, phosphatidylinositol 3′-kinase (PI3k), and mitogen-activated protein kinase (MAPK). Use of a dicistronic reporter with the HIF-1α 5′-untranslated region (5′UTR) between two coding regions indicated that TNF-α promoted an internal ribosome entry site (IRES) rather than a cap-dependent translation. IRES-mediated translation required the functional integrity of the NFκB, PI3k, and MAPK signaling pathways. Although no signal cross-talk was noticed between NFκB, PI3k, and MAPK signaling, these pathways are needed to up-regulate the anti-apoptotic target protein Bcl-2 by TNF-α. Expression of Bcl-2 provoked not only IRES-dependent translation but also HIF-1α protein synthesis. We conclude that Bcl-2 functions as an important determinant in facilitating HIF-1α protein expression by TNF-α via an IRES-dependent translational mechanism. These observations suggest a link between Bcl-2 and HIF-1α expression, a situation with potential relevance to cancer biology.

[1]  R. Bast,et al.  Overexpression of MEKK3 Confers Resistance to Apoptosis through Activation of NFκB* , 2004, Journal of Biological Chemistry.

[2]  D. Trisciuoglio,et al.  bcl-2 Induction of Urokinase Plasminogen Activator Receptor Expression in Human Cancer Cells through Sp1 Activation , 2004, Journal of Biological Chemistry.

[3]  W. Jiang,et al.  Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. , 2003, Diabetes.

[4]  Fengqin Gao,et al.  Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS. , 2003, Blood.

[5]  R. Bruick,et al.  Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. , 2003, Genes & development.

[6]  G. Semenza Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[7]  R. Flavell,et al.  Carbon Monoxide Modulates Fas/Fas Ligand, Caspases, and Bcl-2 Family Proteins via the p38α Mitogen-activated Protein Kinase Pathway during Ischemia-Reperfusion Lung Injury* , 2003, Journal of Biological Chemistry.

[8]  B. Brüne,et al.  Tumor Necrosis Factor- (cid:1) Causes Accumulation of a Ubiquitinated Form of Hypoxia Inducible Factor-1 (cid:1) through a Nuclear Factor- (cid:2) B–Dependent Pathway , 2022 .

[9]  L. Huang,et al.  Hypoxia-inducible Factor and Its Biomedical Relevance* , 2003, Journal of Biological Chemistry.

[10]  P. Ratcliffe,et al.  Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.

[11]  N. Sang,et al.  MAPK Signaling Up-regulates the Activity of Hypoxia-inducible Factors by Its Effects on p300* , 2003, The Journal of Biological Chemistry.

[12]  L. Neckers,et al.  Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. , 2003, The Biochemical journal.

[13]  Tala Bakheet,et al.  p38 Mitogen-Activated Protein Kinase-Dependent and -Independent Signaling of mRNA Stability of AU-Rich Element-Containing Transcripts , 2003, Molecular and Cellular Biology.

[14]  J. Pouysségur,et al.  Induction of Hypoxia-inducible Factor-1α by Transcriptional and Translational Mechanisms* , 2002, The Journal of Biological Chemistry.

[15]  Bing-Hua Jiang,et al.  p38 Signaling-mediated Hypoxia-inducible Factor 1α and Vascular Endothelial Growth Factor Induction by Cr(VI) in DU145 Human Prostate Carcinoma Cells* , 2002, The Journal of Biological Chemistry.

[16]  L. Ellis,et al.  Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells* , 2002, The Journal of Biological Chemistry.

[17]  G. Semenza,et al.  Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway* , 2002, The Journal of Biological Chemistry.

[18]  D. Ribatti,et al.  Bcl-2 Overexpression in Human Melanoma Cells Increases Angiogenesis through Vegf Mrna Stabilization and Hif-1-mediated Transcriptional Activity , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  W. Kaelin How oxygen makes its presence felt. , 2002, Genes & development.

[20]  N. Sang,et al.  Carboxyl-Terminal Transactivation Activity of Hypoxia-Inducible Factor 1α Is Governed by a von Hippel-Lindau Protein-Independent, Hydroxylation-Regulated Association with p300/CBP , 2002, Molecular and Cellular Biology.

[21]  G. Goodall,et al.  Hypoxia-inducible Factor-1 (cid:1) mRNA Contains an Internal Ribosome Entry Site That Allows Efficient Translation during Normoxia and Hypoxia , 2022 .

[22]  D. Peet,et al.  Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.

[23]  B. Brüne,et al.  Regulation of the Hypoxia-inducible Factor 1α by the Inflammatory Mediators Nitric Oxide and Tumor Necrosis Factor-α in Contrast to Desferroxamine and Phenylarsine Oxide* , 2001, The Journal of Biological Chemistry.

[24]  J. Haddad,et al.  A non‐hypoxic, ROS‐sensitive pathway mediates TNF‐α‐dependent regulation of HIF‐1α , 2001 .

[25]  G. Semenza,et al.  HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression , 2001, Molecular and Cellular Biology.

[26]  A. Harris,et al.  Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. , 2001, Cancer research.

[27]  Steve Gerondakis,et al.  The anti‐apoptotic activities of Rel and RelA required during B‐cell maturation involve the regulation of Bcl‐2 expression , 2000, The EMBO journal.

[28]  G. Semenza,et al.  Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. , 2000, Cancer research.

[29]  G. Thomas,et al.  Ribosomal S6 kinase signaling and the control of translation. , 1999, Experimental cell research.

[30]  J. Pouysségur,et al.  p42/p44 Mitogen-activated Protein Kinases Phosphorylate Hypoxia-inducible Factor 1α (HIF-1α) and Enhance the Transcriptional Activity of HIF-1* , 1999, The Journal of Biological Chemistry.

[31]  W. Jelkmann,et al.  Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1 , 1999 .

[32]  Haruo Okado,et al.  Tumor Necrosis Factor Induces Bcl-2 and Bcl-x Expression through NFκB Activation in Primary Hippocampal Neurons* , 1999, The Journal of Biological Chemistry.

[33]  B. Brüne,et al.  NF-κB and AP-1 Activation by Nitric Oxide Attenuated Apoptotic Cell Death in RAW 264.7 Macrophages , 1999 .

[34]  G. Semenza,et al.  The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation. , 1998, Genomics.

[35]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[36]  John Calvin Reed,et al.  Bcl-2 Protects Macrophages from Nitric Oxide-induced Apoptosis* , 1996, The Journal of Biological Chemistry.

[37]  David E. Housman,et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.

[38]  B. Teicher Hypoxia and drug resistance , 1994, Cancer and Metastasis Reviews.

[39]  G. Goodall,et al.  Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. , 2002, Molecular biology of the cell.

[40]  B. Brüne,et al.  Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. , 2001, The Journal of biological chemistry.

[41]  J. Haddad,et al.  A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. , 2001, FEBS letters.

[42]  B. Brüne,et al.  Up-regulation of Bcl-2 by redox signals in glomerular mesangial cells , 2000, Cell Death and Differentiation.

[43]  B. Brüne,et al.  NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. , 1999, Molecular biology of the cell.

[44]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.